Emricasan
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Emricasan, covering 2012-08-10 to 2022-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension [Phase 2]